Breviscapine alleviates liver fibrosis by inhibiting epithelial-mesenchymal transition via TGF-beta1/Smad3 pathway.
- DOI
- 10.1080/10286020.2026.2697867
- Published
- 2026 Jul 14
- Container
- Journal of Asian natural products research
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/10286020.2026.2697867,
title = {Breviscapine alleviates liver fibrosis by inhibiting epithelial-mesenchymal transition via TGF-beta1/Smad3 pathway.},
author = {Zhong XH and Li Y and Song YK and Sun YM and Zhang DF and Ge HC and He YL},
year = {2026},
journal = {Journal of Asian natural products research},
doi = {10.1080/10286020.2026.2697867},
url = {https://doi.org/10.1080/10286020.2026.2697867}
}RIS
TY - JOUR TI - Breviscapine alleviates liver fibrosis by inhibiting epithelial-mesenchymal transition via TGF-beta1/Smad3 pathway. AU - Zhong XH AU - Li Y AU - Song YK AU - Sun YM AU - Zhang DF AU - Ge HC AU - He YL PY - 2026 JO - Journal of Asian natural products research DO - 10.1080/10286020.2026.2697867 UR - https://doi.org/10.1080/10286020.2026.2697867 ER -
APA
XH, Z., Y, L., YK, S., YM, S., DF, Z., HC, G., & YL, H. (2026). Breviscapine alleviates liver fibrosis by inhibiting epithelial-mesenchymal transition via TGF-beta1/Smad3 pathway.. Journal of Asian natural products research. https://doi.org/10.1080/10286020.2026.2697867
Source records
- pubmed · retrieved 2026-09-26T18:22:23.883Z